Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Krystal Biotech Inc
KRYS | US
272.52
USD4.48
1.67%
KRYS | US
Loading StockChartView...
About Krystal Biotech Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
272.52
Open
267.34
High
274.96
Low
259.70
Krystal Biotech Inc. a biotechnology company develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech Inc. was founded in 2016 and is headquartered in Pittsburgh Pennsylvania.
View LessKRYS | US
Risk
32.0
Sharpe
1.45
Luna's Score
61/100
Recommendation
Hold
Luna says (KRYS | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
32.4%1 month
32.0%3 months
36.8%6 months
36.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
45.48
Fwd. PE
25.84
Price to book
6.14
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
38.30
Ent. to rev.
27.65
PEG
-
Other Fundamentals
EBITDA
8.62M
MarketCap
7.83B
MarketCap(USD)
7.83B
Div. yield
-
Op. margin
29.97
Erngs. growth
-
Rev. growth
-
Ret. on equity
14.20
Short ratio
13.69
Short perc.
16.18
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
23.25
Range1M
36.86
Range3M
56.30
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.96
Price X volume
67.79M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 38.30 | 0.53 | Expensive |
| Ent. to Revenue | 27.65 | 3,967.00 | Cheaper |
| PE Ratio | 45.48 | 41.03 | Par |
| Price to Book | 6.14 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 36.76 | 72.80 | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 7.83B | 3.66B | Market Leader |
